Sagimet Biosciences's 15min chart: Bollinger Bands expanding downward, bearish Marubozu.

According to the 15-minute chart of Sagimet Biosciences, the recent price action has triggered the Bollinger Bands Expanding Downward indicator, accompanied by a Bearish Marubozu at 08/22/2025 12:30. This suggests that the market trend is currently being driven by a strong selling pressure, with sellers dominating market activity. As a result, the bearish momentum is likely to persist in the short-term.

Sagimet Biosciences Inc. (SGMT) has been under significant selling pressure, with the stock declining 28% over the past four weeks [2]. Technical indicators such as the Relative Strength Index (RSI) suggest that the stock is currently oversold, with an RSI reading of 29.42 [2]. This indicates that the stock has reached a point where it may experience a trend reversal.

The recent price action on the 15-minute chart of Sagimet Biosciences has triggered the Bollinger Bands Expanding Downward indicator, accompanied by a Bearish Marubozu at 08/22/2025 12:30. This suggests a strong selling pressure, with sellers dominating market activity, and a bearish momentum likely to persist in the short term [2].

Despite the recent downward trend, there is strong agreement among Wall Street analysts that Sagimet Biosciences will report better earnings than previously predicted. The consensus EPS estimate has increased by 13.2% over the last 30 days [2]. Additionally, the company has been upgraded to a Zacks Rank #2 (Buy), indicating that it is in the top 20% of more than 4,000 stocks ranked based on trends in earnings estimate revisions and EPS surprises [1].

While the technical indicators suggest a bearish trend, the fundamental outlook appears positive, with analysts expecting earnings improvements. Investors should monitor the stock closely for signs of a potential turnaround.

References:
[1] https://www.nasdaq.com/articles/sagimet-biosciences-inc-sgmt-upgraded-buy-what-does-it-mean-stock
[2] https://www.nasdaq.com/articles/after-plunging-28-4-weeks-heres-why-trend-might-reverse-sagimet-biosciences-inc-sgmt